Drugs / CAR-T Cell Injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05654077 | Jan → Dec 2022 | nasopharyngeal carcinoma | The Affiliated Hospital of Xuzhou Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05654077 ↗ |
| Modality | Cell therapy | “EBV CAR-T cells” NCT05654077 ↗ |
| Route | Intravenous | “single intravenous infusion of CAR-T cells” NCT05654077 ↗ |